A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

NCT05816382 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
500
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda